跳至主要内容
临床试验/NCT07243444
NCT07243444已完成不适用

Efficacy of Home-Based Telerehabilitation Versus Center-Based Cardiac Rehabilitation on Cardiopulmonary Function and Exercise Capacity in Patients After Coronary Artery Bypass Grafting: A Randomized Controlled Trial

The First Hospital of Hebei Medical University1 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2024年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
110
试验地点
1
主要终点
Change in Peak Oxygen Consumption (VO₂ peak)

研究概览

简要总结

This randomized controlled trial was designed to compare the efficacy of a 12-week home-based telerehabilitation (HBTCR) program against traditional center-based cardiac rehabilitation (CBCR) and usual care in patients who have undergone coronary artery bypass grafting (CABG). The primary goal was to assess changes in cardiopulmonary function, measured by peak oxygen consumption (VO₂ peak), and exercise capacity, measured by the 6-minute walk test (6MWT), to determine if HBTCR is a viable alternative to CBCR.

详细描述

While cardiac rehabilitation (CR) is a Class IA recommendation for patients after coronary artery bypass grafting (CABG) to improve long-term outcomes, participation in traditional center-based programs (CBCR) is low due to barriers like travel, cost, and scheduling. Home-based telerehabilitation (HBTCR) emerges as a potential solution. This study was a three-arm, prospective, single-center randomized controlled trial to rigorously evaluate if a structured HBTCR program is as effective as CBCR. A total of 110 patients, 4-8 weeks post-CABG, were randomized into three groups: HBTCR, CBCR, or a control group receiving usual care with educational pamphlets. The HBTCR group performed prescribed exercises at home, using wearable monitors and a mobile app, with weekly remote monitoring by a rehabilitation team. The CBCR group attended supervised sessions at the hospital three times a week. The control group received standard follow-up and educational materials. The interventions lasted 12 weeks, with assessments of cardiopulmonary function, exercise capacity, cardiac function, psychological status, and quality of life conducted at baseline and at 12 weeks. The study aimed to provide robust evidence for HBTCR as an effective alternative model of care for post-CABG rehabilitation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
30 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged 30 to 75 years.
  • Had undergone Coronary Artery Bypass Grafting (CABG) 4 to 8 weeks prior.
  • In a stable clinical condition.
  • Able to provide written informed consent.
  • No cognitive impairments.

排除标准

  • Acute decompensated heart failure.
  • Severe physical comorbidities (e.g., fractures, severe hearing impairment) that would preclude participation in an exercise program.
  • Recent stroke or pulmonary embolism.
  • Significant hepatic or renal dysfunction.
  • Unstable angina.

结局指标

主要结局

Change in Peak Oxygen Consumption (VO₂ peak)

时间窗: Baseline, 12 weeks

Measured in mL/kg/min by cardiopulmonary exercise testing (CPET) on a treadmill using a symptom-limited protocol. The change from baseline to 12 weeks was assessed.

Change in 6-Minute Walk Distance (6MWD)

时间窗: Baseline, 12 weeks

Measured in meters, assessing the maximum distance a patient can walk in 6 minutes on a flat, hard surface. The change from baseline to 12 weeks was assessed.

次要结局

  • Change in Left Ventricular Ejection Fraction (LVEF)(Baseline, 12 weeks)
  • Change in Forced Expiratory Volume in 1 second to Forced Vital Capacity Ratio (FEV1/FVC)(Baseline, 12 weeks)
  • Change in Psychological Status (Anxiety)(Baseline, 12 weeks)
  • Change in Psychological Status (Depression)(Baseline, 12 weeks)
  • Change in Quality of Life(Baseline, 12 weeks)
  • Change in Cardiac Index (CI)(Baseline, 12 weeks)
  • Adherence to Rehabilitation Program(Up to 12 weeks)
  • Incidence of Major Adverse Events(Up to 12 weeks)
  • Change in Stroke Volume Index (SVI)(Baseline, 12 weeks)
  • Change in Systemic Vascular Resistance Index (SVRI)(Baseline, 12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yan Liu

Principal investigator

The First Hospital of Hebei Medical University

研究点 (1)

Loading locations...

相似试验